<?xml version="1.0" ?>
<document id="3fb8269503a524e2257482ce479a05abd732ddfe">
  <chunk id="3fb8269503a524e2257482ce479a05abd732ddfe.c0" text="Carcinoembryonic antigen (CEA)-related cell adhesion molecules are co-expressed in the human lung and their expression can be modulated in bronchial epithelial cells by non-typable Haemophilus influenzae, Moraxella catarrhalis, TLR3, and type I and II interferons">
    <entity charOffset="39-52" id="3fb8269503a524e2257482ce479a05abd732ddfe.c0.e0" ontology_id="GO_0007155" text="cell adhesion" type="gene_function"/>
  </chunk>
  <chunk id="3fb8269503a524e2257482ce479a05abd732ddfe.c1" text="Background: The carcinoembryonic antigen (CEA)-related cell adhesion molecules CEACAM1 (BGP, CD66a), CEACAM5 (CEA, CD66e) and CEACAM6 (NCA, CD66c) are expressed in human lung. They play a role in innate and adaptive immunity and are targets for various bacterial and viral adhesins. Two pathogens that colonize the normally sterile lower respiratory tract in patients with chronic obstructive pulmonary disease (COPD) are non-typable Haemophilus influenzae (NTHI) and Moraxella catarrhalis. Both pathogens bind to CEACAMs and elicit a variety of cellular reactions, including bacterial internalization, cell adhesion and apoptosis.">
    <entity charOffset="55-68" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e0" ontology_id="GO_0007155" text="cell adhesion" type="gene_function"/>
    <entity charOffset="373-380" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e1" ontology_id="HP_0011010" text="chronic" type="phenotype"/>
    <entity charOffset="373-410" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e2" ontology_id="HP_0006510" text="chronic obstructive pulmonary disease" type="phenotype"/>
    <entity charOffset="412-416" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e3" ontology_id="HP_0006510" text="COPD" type="phenotype"/>
    <entity charOffset="603-616" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e4" ontology_id="GO_0007155" text="cell adhesion" type="gene_function"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e0" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e1" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p0" relation="true"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e0" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e2" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p1" relation="true"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e0" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e3" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p2" relation="true"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e1" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e4" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p3" relation="true"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e2" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e4" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p4" relation="true"/>
    <pair e1="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e3" e2="3fb8269503a524e2257482ce479a05abd732ddfe.c1.e4" id="3fb8269503a524e2257482ce479a05abd732ddfe.c1.p5" relation="true"/>
  </chunk>
  <chunk id="3fb8269503a524e2257482ce479a05abd732ddfe.c2" text="Methods: To analyze the (co-) expression of CEACAM1, CEACAM5 and CEACAM6 in different lung tissues with respect to COPD, smoking status and granulocyte infiltration, immunohistochemically stained paraffin sections of 19 donors were studied. To address short-term effects of cigarette smoke and acute inflammation, transcriptional regulation of CEACAM5, CEACAM6 and different CEACAM1 isoforms by cigarette smoke extract, interferons, Toll-like receptor agonists, and bacteria was tested in normal human bronchial epithelial (NHBE) cells by quantitative PCR. Corresponding CEACAM protein levels were determined by flow cytometry.">
    <entity charOffset="294-299" id="3fb8269503a524e2257482ce479a05abd732ddfe.c2.e0" ontology_id="HP_0011009" text="acute" type="phenotype"/>
  </chunk>
  <chunk id="3fb8269503a524e2257482ce479a05abd732ddfe.c3" text="Results: Immunohistochemical analysis of lung sections showed the most frequent and intense staining for CEACAM1, CEACAM5 and CEACAM6 in bronchial and alveolar epithelium, but revealed no significant differences in connection with COPD, smoking status and granulocyte infiltration. In NHBE cells, mRNA expression of CEACAM1 isoforms CEACAM1-4L, CEACAM1-4S, CEACAM1-3L and CEACAM1-3S were up-regulated by interferons alpha, beta and gamma, as well as the TLR3 agonist polyinosinic:polycytidylic acid (poly I:C). Interferon-gamma also increased CEACAM5 expression. These results were confirmed on protein level by FACS analysis. Importantly, also NTHI and M. catarrhalis increased CEACAM1 mRNA levels. This effect was independent of the ability to bind to CEACAM1. The expression of CEACAM6 was not affected by any treatment or bacterial infection.">
    <entity charOffset="71-79" id="3fb8269503a524e2257482ce479a05abd732ddfe.c3.e0" ontology_id="HP_0040282" text="frequent" type="phenotype"/>
    <entity charOffset="797-805" id="3fb8269503a524e2257482ce479a05abd732ddfe.c3.e1" ontology_id="HP_0032320" text="affected" type="phenotype"/>
  </chunk>
  <chunk id="3fb8269503a524e2257482ce479a05abd732ddfe.c4" text="Conclusions: While we did not find a direct correlation between CEACAM1 expression and COPD, the COPD-associated bacteria NTHi and M. catarrhalis were able to increase the expression of their own receptor on host cells. Further, the data suggest a role for CEACAM1 and CEACAM5 in the phenomenon of increased host susceptibility to bacterial infection upon viral challenge in the human respiratory tract."/>
</document>
